792 filings
Page 10 of 40
10-Q
2019 Q2
TGTX
TG Therapeutics Inc
Quarterly report
9 Aug 19
4:31pm
8-K
TGTX
TG Therapeutics Inc
9 Aug 19
Results of Operations and Financial Condition
7:33am
4
Power Sean A
3 Jul 19
TG THERAPEUTICS / Sean A Power ownership change
4:00pm
4
Weiss Michael S
27 Jun 19
TG THERAPEUTICS / MICHAEL S WEISS ownership change
7:33am
4
Weiss Michael S
14 Jun 19
TG THERAPEUTICS / MICHAEL S WEISS ownership change
4:43pm
8-K
TGTX
TG Therapeutics Inc
13 Jun 19
Submission of Matters to a Vote of Security Holders
4:07pm
SC 13G/A
TGTX
TG Therapeutics Inc
7 Jun 19
TG Therapeutics, Inc.
4:58pm
PX14A6G
TGTX
TG Therapeutics Inc
31 May 19
Letter to shareholders
2:48pm
10-Q
2019 Q1
TGTX
TG Therapeutics Inc
Quarterly report
10 May 19
4:01pm
8-K
TGTX
TG Therapeutics Inc
10 May 19
TG Therapeutics Provides Business Update and Reports First Quarter 2019 Financial Results
7:01am
8-K
TGTX
TG Therapeutics Inc
8 May 19
Ublituximab treatment continues to be well tolerated with a median duration of follow-up of 97.5 weeks
12:00am
DEFA14A
TGTX
TG Therapeutics Inc
30 Apr 19
Additional proxy soliciting materials
4:35pm
DEF 14A
TGTX
TG Therapeutics Inc
Definitive proxy
30 Apr 19
4:31pm
8-K
TGTX
TG Therapeutics Inc
1 Apr 19
Other Events
8:33am
SC 13G
Bridger Management, LLC
11 Mar 19
TG Therapeutics, Inc.
4:06pm
SC 13G
TGTX
TG Therapeutics Inc
7 Mar 19
TG Therapeutics, Inc.
5:09pm
424B5
TGTX
TG Therapeutics Inc
5 Mar 19
Prospectus supplement for primary offering
9:01am
8-K
TGTX
TG Therapeutics Inc
5 Mar 19
Entry into a Material Definitive Agreement
9:00am
10-K
2018 FY
TGTX
TG Therapeutics Inc
Annual report
1 Mar 19
12:00am
424B5
TGTX
TG Therapeutics Inc
28 Feb 19
Prospectus supplement for primary offering
4:02pm